JWW-1 human chimeric antibody Citations (3)
Originally described in: Sero-epidemiology of HPV16 L2 and generation of papillomavirus L2-specific human chimeric monoclonal antibodies.Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB Clin Vaccine Immunol. 2015 May 13. pii: CVI.00799-14. PubMed Journal
Articles Citing JWW-1 human chimeric antibody
| Articles |
|---|
| Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide. Yan H, Foo SS, Chen W, Yoo JS, Shin WJ, Wu C, Jung JU. mBio. 2019 Aug 6;10(4). pii: mBio.01834-19. doi: 10.1128/mBio.01834-19. PubMed |
Engineered cell entry links receptor biology with single-cell genomics.
Yu B, Shi Q, Belk JA, Yost KE, Parker KR, Li R, Liu BB, Huang H, Lingwood D, Greenleaf WJ, Davis MM, Satpathy AT, Chang HY.
Cell. 2022 Dec 22;185(26):4904-4920.e22. doi: 10.1016/j.cell.2022.11.016. Epub 2022 Dec 13.
PubMed
Associated Plasmids |
| Engineering of BZ transposase and transposon donor vector for enhanced efficiency and safety in gene delivery applications. Wang S, Zhang P, Sun Y, Fang Y, Wang P, Shao M, Zhang N, Shi S, Chen X, Gao H, Cheng J, Gao B, Liu T, Qian Q, Song C. Nucleic Acids Res. 2025 Sep 23;53(18):gkaf935. doi: 10.1093/nar/gkaf935. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.